Distinctive Flow Cytometric and Mutational Profile of Acute Myeloid Leukemia With t(8;16)(p11;p13) Translocation

Abstract

Objectives Acute myeloid leukemia (AML) with t(8;16)(p11;p13) abnormalities is a rare, aggressive, and diagnostically challenging subtype that results in KAT6A-CREBBP gene fusion. Methods To investigate their immunophenotype and genomic features, we identified 5 cases of AML with t(8;16) through a retrospective review of the databases at Northwestern Memorial Hospital in Chicago, IL, and Washington University Medical Center, in St Louis, MO. Results In all, 4 of 5 cases were therapy related and 1 was possibly therapy related. The leukemic blasts showed distinctive features, including bright CD45 expression and remarkably high side scatter that overlapped with maturing myeloid elements, making the blasts difficult to identify on initial examination. They were positive for CD13, CD33, and CD64 and negative for CD34 and CD117. Next-generation sequencing profiling of 4 cases revealed pathogenic ASXL1 (2 cases), FLT3-tyrosine kinase domain (TKD) mutations (2 cases), and other pathogenic mutations. In 3 patients, t(8;16) was the sole cytogenetic abnormality; additional aberrations were found in 2 patients. Single nucleotide polymorphism microarray revealed 1 case with 7q deletion as a secondary clone. Conclusions Our data highlight the distinctive immunophenotypic profile of AML with t(8;16), which, along with its unique morphology, often presents a diagnostic challenge. We showed that mutations of either ASXL1 or FLT3-TKD are seen in most cases of this leukemia.

Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis

“…Common clinical symptoms of leukemia are various anemic blood pictures, uncertain bleeding, common infections and body fever, and enlargement of vital body organs, including liver, spleen, lymph adenomegaly, and skeletal pain [ 3 – 6 ]. Acute myeloid leukemia (AML) is a cancer of blood cell myeloid cell lines defined by the rapid growth of abnormal leukocytes, accumulating in the patient's bone marrow and interfering with the normal blood cells production, and its incidence increases with age [ 7 – 10 ]. In our country, 3-4 people develop leukemia per 100,000 people.…”

The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia

“…Four of the five CHD4 lesions occurred in HOXA cases, further supporting their functional relevance. A second gene, lysine acetyltransferase 6A ( KAT6A ), a histone acetyltransferase mutated in AML, 26 harbored variants in four cases including a focal deletion and three truncating frameshift events likely to result in loss of function (Data Supplement [Fig A5]).…”